GCL is the rate-limiting enzyme in glutathione biosynthesis and genetic polymorphisms in its catalytic (GCLC) and modifying (GCLM) subunits were associated with increased susceptibility to oxidative stress and with increased MI risk in the general population and T2D patients [96]. This evidence concerns the gene GCLM and type 2 diabetes mellitus.